Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Rio-Machin

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|July 8, 2024
GATA2 deficiency syndrome: A compensatory mechanism gone awry?Ana Rio-Machin
British Journal of Haematology|December 22, 2019
AML through the prism of molecular geneticsSarah Charrot, Hannah Armes, Ana Rio-Machin, et al.
Seminars in Hematology|June 23, 2017
Familial CEBPA-mutated acute myeloid leukemiaKiran Tawana, Ana Rio-Machin, Claude Preudhomme, et al.
Nature Communications|July 16, 2020
Endogenous retroviruses are a source of enhancers with oncogenic potential in acute myeloid leukaemiaÖzgen Deniz, Mamataz Ahmed, Christopher D Todd, et al.
RNA (New York, N.Y.)|June 29, 2022
A dual role for the RNA helicase DHX34 in NMD and pre-mRNA splicing and its function in hematopoietic differentiationNele Hug, Stuart Aitken, Dasa Longman, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2020
A frameshift variant in specificity protein 1 triggers superactivation of Sp1-mediated transcription in familial bone marrow failureHemanth Tummala, Amanda J Walne, Findlay Bewicke-Copley, et al.
European Journal of Human Genetics : EJHG|May 18, 2017
Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigreeKiran Tawana, Jun Wang, Péter A Király, et al.
Science Translational Medicine|June 22, 2022
CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemiaWilliam Grey, Ana Rio-Machin, Pedro Casado, et al.
British Journal of Haematology|February 6, 2023
Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working GroupBeverley Speight, Helen Hanson, Clare Turnbull, et al.
British Journal of Haematology|September 26, 2022
Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironmentHannah Armes, Findlay Bewicke-Copley, Ana Rio-Machin, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|July 8, 2024
GATA2 deficiency syndrome: A compensatory mechanism gone awry?Ana Rio-Machin
British Journal of Haematology|December 22, 2019
AML through the prism of molecular geneticsSarah Charrot, Hannah Armes, Ana Rio-Machin, et al.
Seminars in Hematology|June 23, 2017
Familial CEBPA-mutated acute myeloid leukemiaKiran Tawana, Ana Rio-Machin, Claude Preudhomme, et al.
Nature Communications|July 16, 2020
Endogenous retroviruses are a source of enhancers with oncogenic potential in acute myeloid leukaemiaÖzgen Deniz, Mamataz Ahmed, Christopher D Todd, et al.
RNA (New York, N.Y.)|June 29, 2022
A dual role for the RNA helicase DHX34 in NMD and pre-mRNA splicing and its function in hematopoietic differentiationNele Hug, Stuart Aitken, Dasa Longman, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2020
A frameshift variant in specificity protein 1 triggers superactivation of Sp1-mediated transcription in familial bone marrow failureHemanth Tummala, Amanda J Walne, Findlay Bewicke-Copley, et al.
European Journal of Human Genetics : EJHG|May 18, 2017
Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigreeKiran Tawana, Jun Wang, Péter A Király, et al.
Science Translational Medicine|June 22, 2022
CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemiaWilliam Grey, Ana Rio-Machin, Pedro Casado, et al.
British Journal of Haematology|February 6, 2023
Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working GroupBeverley Speight, Helen Hanson, Clare Turnbull, et al.
British Journal of Haematology|September 26, 2022
Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironmentHannah Armes, Findlay Bewicke-Copley, Ana Rio-Machin, et al.
Pageof 2